Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine for prevention of postoperative atrial fibrillation after cardiac surgery
ACTRN12613001345774Phase 3Recruiting
- Sponsor
- Barwon Health
- Start
- Oct 2013
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of colchicine in Atrial fibrillation (AFib), sponsored by Barwon Health. Primary endpoint: Incidence of postoperative atrial fibrillation. Started Oct 2013; status: recruiting.
02
Drugs
colchicine
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on ACTRN12613001345774.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613001345774.